Home
Amylyx Pharmaceuticals AMLX paid Tarplin, Downs & Young $40K for lobbying in Q3 2025 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $40,000
- Quarter
- Q3 2025
- Client
- Amylyx Pharmaceuticals
- Reported
- 25/10/16
Up 0.0% from last quarter
What else happened in Amylyx Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Amylyx Pharmaceuticals's other lobbying reports
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 07/16
for Q2
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 04/20
for Q1
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 01/20
for Q4 2025
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 25/07/16
for Q2 2025
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
Under $5,000
Under $5,000
Reported 25/04/21
for Q1 2025